source
- BioNTech plans to cut up to 1,860 manufacturing jobs as it scales down production footprintBioNTech announced in its first‑quarter earnings release that it will reduce its manufacturing footprint. The company said the restructuring could affect as many as 1,860 employees working in its…
- Pfizer halts final Trillium study, redirects R&D funds to cancer and obesity programsPfizer announced it is ending the last clinical trial that originated from its 2021 purchase of Trillium Therapeutics. The company said the decision will free up cash that will be redirected to a…